Skip to content
101010555

Drawing based on the label description. No photo yet.

10 5 pill

Pill with imprint 10 5 is yellow, triangle, 8 mm and has been identified as Empagliflozin and Linagliptin 10 mg / 5 mg. It is used for type 2 diabetes. It is supplied by Boehringer Ingelheim Pharmaceuticals, Inc.

Empagliflozin and Linagliptin 10 mg / 5 mg

Imprint
10 5
Strength
Empagliflozin 10 mg / Linagliptin 5 mg
Used for
Type 2 diabetes
Color
Yellow
Shape
Triangle
Size
8 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Boehringer Ingelheim Pharmaceuticals, Inc
Drug class
Diabetes medicine (SGLT2 inhibitor)
NDC
0597-0182, 0597-0182-70, 0597-0182-07, 0597-0182-03, 0597-0182-30, 0597-0182-39, 0597-0182-90

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Empagliflozin and Linagliptin pills and guides

What is Empagliflozin and Linagliptin used for?

Empagliflozin and Linagliptin is used for type 2 diabetes.

Medicine type
Diabetes medicine (SGLT2 inhibitor); diabetes medicine (DPP-4 inhibitor)
Official uses from the US prescribing label

GLYXAMBI is a combination of empagliflozin and linagliptin indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Empagliflozin is indicated to reduce the risk of cardiovascular (CV) death in adults with type 2 diabetes mellitus and established CV disease.

Limitations of Use

GLYXAMBI is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus. It may increase the risk of diabetic ketoacidosis in these patients.

GLYXAMBI has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using GLYXAMBI.

GLYXAMBI is not recommended for use to improve glycemic control in adults with type 2 diabetes mellitus with an eGFR less than 30 mL/min/1.73 m2. GLYXAMBI is likely to be ineffective in this setting based upon its mechanism of action.

From the FDA-approved label on DailyMed (published Feb 02, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows 10 5. The parts can be split between the two sides, so turn the pill over and check both.
  • It is yellow, triangle, 8 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Glyxambi.

Ingredients

Active: Empagliflozin, Linagliptin

Other pills with imprint 10 5

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Empagliflozin and Linagliptin pills